{"id":"W2138335151","doi":"10.5489/cuaj.66","title":"Systemic therapy for patients with advanced, unresectable or metastatic renal cell carcinoma: moving to guidelines","year":2012,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St Joseph's Health Care; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Sorafenib; Sunitinib; Renal cell carcinoma; Medicine; Sunitinib malate; Bevacizumab; Context (archaeology); Angiogenesis; Oncology; Internal medicine; Cancer research; Targeted therapy; Kidney cancer; Clear cell; Cancer; Chemotherapy; PI3K/AKT/mTOR pathway; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; Biology; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003137886,0.0005647485,0.001099541,0.0009529337,0.001168194,0.001363534,0.001502523,0.003296943,0.002958821],"category_scores_gemma":[0.005499575,0.0002043808,0.0005768418,0.001122226,0.001086508,0.001830964,0.00122714,0.007980486,0.001776656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003096475,"about_ca_system_score_gemma":0.01058773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01935302,"about_ca_topic_score_gemma":0.06572498,"domain_scores_codex":[0.9982181,0.0005873296,0.0003347282,0.00009448973,0.0006546307,0.0001106448],"domain_scores_gemma":[0.9953369,0.0008869639,0.0004301571,0.0001018409,0.002297303,0.0009468995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005580772,0.0001835536,0.003049284,0.001261717,0.00004936102,0.000652269,0.0003321576,0.0007979817,0.0009035379,0.007013606,0.5923832,0.3933176],"study_design_scores_gemma":[0.0001073043,0.0001425741,0.006306918,0.005133783,0.00007080911,0.001553011,0.0004368885,0.0007748007,0.0002962566,0.008830016,0.9763061,0.00004152581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.00336358,0.1855931,0.01095794,0.758815,0.006136935,0.0002435866,0.000341747,0.0003582407,0.03418991],"genre_scores_gemma":[0.06112773,0.4963205,0.08770791,0.3051929,0.01990942,0.0007157067,0.001665047,0.0002501221,0.02711064],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01935302,"threshold_uncertainty_score":0.03848076,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03359954766063696,"score_gpt":0.2682998254765048,"score_spread":0.2347002778158678,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}